SCHEMBL25849462

SCHEMBL25849462

Cc1ccc(Oc2ccc(-c3c(C)[nH]c4c(c3=O)CCCC4)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 1/20 0.50
SLC2A1 P11166 1/20 0.48
BRD4 O60885 5/20 0.46
CUL4A Q13619 2/20 0.39
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
BCHE P06276 2/20 0.37
ACHE P22303 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
MAPK10 P53779 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DCTPP1 Q9H773 1/20 0.37
POLB P06746 1/20 0.36
TEAD4 Q15561 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19032056 0.91 SLC2A1 (0.47) PDE9ASLC2A1BRD4CUL4AALDH1A1
SCHEMBL19032069 0.90 SLC2A1 (0.46) PDE9ASLC2A1BRD4CUL4AALDH1A1
SCHEMBL19032086 0.90 SLC2A1 (0.62) PDE9ASLC2A1BRD4CUL4AALDH1A1
SCHEMBL25849408 0.88 BRD4 (0.45) PDE9ASLC2A1BRD4MAPTBCHE
SCHEMBL19032416 0.88 SLC2A1 (0.53) PDE9ASLC2A1BRD4CUL4AALDH1A1
SCHEMBL19032107 0.87 SLC2A1 (0.43) PDE9ASLC2A1BRD4CUL4AALDH1A1
SCHEMBL19032098 0.87 BRD4 (0.44) PDE9ASLC2A1BRD4CUL4AALDH1A1
SCHEMBL19032058 0.87 SLC2A1 (0.43) PDE9ASLC2A1BRD4CUL4AALDH1A1
SCHEMBL19032141 0.86 SLC2A1 (0.48) PDE9ASLC2A1BRD4CUL4AALDH1A1
SCHEMBL29768840 0.86 SLC2A1 (0.48) PDE9ASLC2A1BRD4CUL4AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230181564-A1 Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites THE UNIVERSITY OF SHEFFIELD (GB) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230181564-A1 Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites CYP11B2, CYP11B1, COX5B PDE9A 1605/4885SLC2A1 4289/4885BRD4 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.